Beware of buzzwords when investing in a new technology, says Derek Lowe at In the Pipeline. He makes fun of an announcement released earlier this year by Primegen, saying that they used carbon nanotubes to reprogram stem cells. Though both are hot fields, they're also still very new. "So what are the odds of getting them to work together? Not as good as the odds that someone thought the combination would make a good press release, I'm afraid," he says.